Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2016

01.03.2016

A Difference-in-Difference Analysis of Changes in Quality, Utilization and Cost Following the Colorado Multi-Payer Patient-Centered Medical Home Pilot

verfasst von: Meredith B. Rosenthal, Ph.D., Shehnaz Alidina, M.P.H., S.D., Mark W. Friedberg, M.D., M.P.P., Sara J. Singer, M.B.A., Ph.D., Diana Eastman, B.A., Zhonghe Li, M.S., Eric C. Schneider, M.D., M.Sc.

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Research on the effects of patient-centered medical homes on quality and cost of care is mixed, so further study is needed to understand how and in what contexts they are effective.

OBJECTIVE

We aimed to evaluate effects of a multi-payer pilot promoting patient-centered medical home implementation in 15 small and medium-sized primary care groups in Colorado.

DESIGN

We conducted difference-in-difference analyses, comparing changes in utilization, costs, and quality between patients attributed to pilot and non-pilot practices.

PARTICIPANTS

Approximately 98,000 patients attributed to 15 pilot and 66 comparison practices 2 years before and 3 years after the pilot launch.

MAIN MEASURES

Healthcare Effectiveness Data and Information Set (HEDIS) derived measures of diabetes care, cancer screening, utilization, and costs to payers.

KEY RESULTS

At the end of two years, we found a statistically significant reduction in emergency department use by 1.4 visits per 1000 member months, or approximately 7.9 % (p = 0.02). At the end of three years, pilot practices sustained this difference with 1.6 fewer emergency department visits per 1000 member months, or a 9.3 % reduction from baseline (p = 0.01). Emergency department costs were lower in the pilot practices after two (13.9 % reduction, p < 0.001) and three years (11.8 % reduction, p = 0.001). After three years, compared to control practices, primary care visits in the pilot practices decreased significantly (1.5 % reduction, p = 0.02). The pilot was associated with increased cervical cancer screening after two (12.5 % increase, p < 0.001) and three years (9.0 % increase, p < 0.001), but lower rates of HbA1c testing in patients with diabetes (0.7 % reduction at three years, p = 0.03) and colon cancer screening (21.1 % and 18.1 % at two and three years, respectively, p < 0.001). For patients with two or more comorbidities, similar patterns of association were found, except that there was also a reduction in ambulatory care sensitive inpatient admissions (10.3 %; p = 0.05).

CONCLUSION

Our findings suggest that a multi-payer, patient-centered medical home initiative that provides financial and technical support to participating practices can produce sustained reductions in utilization with mixed results on process measures of quality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Peikes D, Zutshi A, Genevro JL, Parchman ML, Meyers DS. Early evaluations of the medical home: building on a promising start. Am J Manag Care. 2012;18(2):105–116.PubMed Peikes D, Zutshi A, Genevro JL, Parchman ML, Meyers DS. Early evaluations of the medical home: building on a promising start. Am J Manag Care. 2012;18(2):105–116.PubMed
6.
Zurück zum Zitat Gilfillan RJ, Tomcavage J, Rosenthal MB, et al. Value and the medical home: effects of transformed primary care. Am J Manag Care. 2010;16(8):607–614.PubMed Gilfillan RJ, Tomcavage J, Rosenthal MB, et al. Value and the medical home: effects of transformed primary care. Am J Manag Care. 2010;16(8):607–614.PubMed
7.
Zurück zum Zitat Reid RJ, Coleman K, Johnson EA, et al. The group health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood). 2010;29(5):835–843. doi:10.1377/hlthaff.2010.0158.CrossRef Reid RJ, Coleman K, Johnson EA, et al. The group health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood). 2010;29(5):835–843. doi:10.​1377/​hlthaff.​2010.​0158.CrossRef
8.
Zurück zum Zitat Rosenthal MB, Friedberg MW, Singer SJ, Eastman D, Li Z, Schneider EC. Effect of a multipayer patient-centered medical home on health care utilization and quality: The rhode island chronic care sustainability initiative pilot program. JAMA Intern Med. 2013;173(20):1907–1913. doi:10.1001/jamainternmed.2013.10063.CrossRefPubMed Rosenthal MB, Friedberg MW, Singer SJ, Eastman D, Li Z, Schneider EC. Effect of a multipayer patient-centered medical home on health care utilization and quality: The rhode island chronic care sustainability initiative pilot program. JAMA Intern Med. 2013;173(20):1907–1913. doi:10.​1001/​jamainternmed.​2013.​10063.CrossRefPubMed
10.
Zurück zum Zitat Friedberg MW, Schneider EC, Rosenthal MB, Volpp KG, Werner RM. Association between participation in a multipayer medical home intervention and changes in quality, utilization, and costs of care. JAMA. 2014;311(8):815–825. doi:10.1001/jama.2014.353.CrossRefPubMed Friedberg MW, Schneider EC, Rosenthal MB, Volpp KG, Werner RM. Association between participation in a multipayer medical home intervention and changes in quality, utilization, and costs of care. JAMA. 2014;311(8):815–825. doi:10.​1001/​jama.​2014.​353.CrossRefPubMed
11.
Zurück zum Zitat Tomoaia-Cotisel A, Scammon DL, Waitzman NJ, et al. Context matters: the experience of 14 research teams in systematically reporting contextual factors important for practice change. Ann Fam Med. 2013;11(Suppl 1):S115–S123. doi:10.1370/afm.1549.PubMedCentralCrossRefPubMed Tomoaia-Cotisel A, Scammon DL, Waitzman NJ, et al. Context matters: the experience of 14 research teams in systematically reporting contextual factors important for practice change. Ann Fam Med. 2013;11(Suppl 1):S115–S123. doi:10.​1370/​afm.​1549.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat NCQA (National Committee for Quality Assurance). Standards and Guidelines for NCQA’s Patient-Centered Medical Home (PCMH) 2014. NCQA (National Committee for Quality Assurance). Standards and Guidelines for NCQA’s Patient-Centered Medical Home (PCMH) 2014.
13.
Zurück zum Zitat Alidina S, Rosenthal M, Schneider E. Collaborating within Medical Neighborhoods: Insights from Patient-Centered Medical Homes in Colorado. Alidina S, Rosenthal M, Schneider E. Collaborating within Medical Neighborhoods: Insights from Patient-Centered Medical Homes in Colorado.
14.
Zurück zum Zitat National Committee for Quality Assurance. Healthcare Effectiveness Data and Information Set. 2011. National Committee for Quality Assurance. Healthcare Effectiveness Data and Information Set. 2011.
17.
Zurück zum Zitat Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.CrossRefPubMed Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.CrossRefPubMed
18.
Zurück zum Zitat Austin PA. Comparison of Twelve Algorithms for Matching on the Propensity Score. Statist Med. 2014;33:1057–1069. Austin PA. Comparison of Twelve Algorithms for Matching on the Propensity Score. Statist Med. 2014;33:1057–1069.
19.
Zurück zum Zitat Karaca-Mandic P, Norton EC, Dowd B. Interaction terms in non-linear models. HSR 47(1), Part I: 255–274. Karaca-Mandic P, Norton EC, Dowd B. Interaction terms in non-linear models. HSR 47(1), Part I: 255–274.
20.
Zurück zum Zitat Buntin M, Zaslavsky A. Too Much Ado about Two-part Models and Transformation? Comparing Methods of Modeling Medicare Expenditures. J Health Econ. 2004;23(3):525–542. Buntin M, Zaslavsky A. Too Much Ado about Two-part Models and Transformation? Comparing Methods of Modeling Medicare Expenditures. J Health Econ. 2004;23(3):525–542.
21.
Zurück zum Zitat Reid RJ, Fishman PA, Yu O, et al. Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care. 2009;15(9):e71–e87. Reid RJ, Fishman PA, Yu O, et al. Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care. 2009;15(9):e71–e87.
23.
Zurück zum Zitat Colla CH, Fisher ES. Beyond PCMHs and Accountable Care Organizations: Payment Reform That Encourages Customized Care. J Gen Intern Med. 2014:1–3. doi:10.1007/s11606-014-2928-4. Colla CH, Fisher ES. Beyond PCMHs and Accountable Care Organizations: Payment Reform That Encourages Customized Care. J Gen Intern Med. 2014:1–3. doi:10.​1007/​s11606-014-2928-4.
Metadaten
Titel
A Difference-in-Difference Analysis of Changes in Quality, Utilization and Cost Following the Colorado Multi-Payer Patient-Centered Medical Home Pilot
verfasst von
Meredith B. Rosenthal, Ph.D.
Shehnaz Alidina, M.P.H., S.D.
Mark W. Friedberg, M.D., M.P.P.
Sara J. Singer, M.B.A., Ph.D.
Diana Eastman, B.A.
Zhonghe Li, M.S.
Eric C. Schneider, M.D., M.Sc.
Publikationsdatum
01.03.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2016
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3521-1

Weitere Artikel der Ausgabe 3/2016

Journal of General Internal Medicine 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.